FdaApplication
NDA 209191
Identifiers
- fda_app_no: NDA209191
Properties
| Property | Value |
|---|---|
| applicant_name | HOSPIRA INC |
| application_type | NDA |
| approval_date | 2022-05-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BORTEZOMIB | BORTEZOMIB | 1MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS |
| BORTEZOMIB | BORTEZOMIB | 2.5MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS |
2 products